Ola Adebayo

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “CD47-targeting antibodies as a novel therapeutic strategy in hematologic malignancies”.

CD47-targeting antibodies as a novel therapeutic strategy in hematologic malignancies

Leukemia Research Reports(2021)10.1016/j.lrr.2021.100268

N/A

0DataRank · unranked

25 citations

Yixuan Chen, Berit Lubben, Ola Adebayo, Barbara Muz, Abdel Kareem Azab +1 more

Nanoparticle T cell engagers for the treatment of acute myeloid leukemia

Oncotarget(2021)10.18632/oncotarget.28054

N/A

0DataRank · unranked

11 citations

Jennifer Sun, Barbara Muz, Amanda Jeske, Jessica Yavner, Hannah Bash +7 more

Coffee, Tea, and Mammographic Breast Density in Premenopausal Women

Nutrients(2021)10.3390/nu13113852

N/A

0DataRank · unranked

0 citations

Valerie Otti, Shuai Xu, Ola Adebayo, Adetunji T. Toriola, Adashi Margaret Odama

Targeted Cancer Immunotherapy by Nanoparticle T Cell Engagers

The FASEB Journal(2022)10.1096/fasebj.2022.36.s1.r2489

N/A

0DataRank · unranked

0 citations

Kinan Alhallak, Jennifer K. Sun, Barbara Muz, Hannah Bash, Chaelee Park +5 more